MedTrace Logo

Real World Evidence on the Use of Medical Cannabis in Pediatrics

NCT05863910 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-11-30

No results posted yet for this study

Summary

CAN-RWE is an observational study that is following 500 children who have authorizations for medical cannabis for two years from across Canada.

Conditions

Interventions

DRUG

Medical Cannabis

Any cannabis product that is available to participants through the Medical Cannabis Access Program is eligible to be included in this study.

Sponsors & Collaborators

  • The Canadian Collaborative for Childhood Cannabinoid Therapeutics

    collaborator UNKNOWN

  • Canadian Cancer Society (CCS)

    collaborator OTHER

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • University of Manitoba

    lead OTHER

Principal Investigators

  • Sapna Oberoi, MD · University of Manitoba

  • Taylor Lougheed, MD · Northern Ontario School of Medicine

  • Evan Lewis, MD · Neurology Centre of Toronto

Eligibility

Min Age
3 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-20
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05863910 on ClinicalTrials.gov